Search

everythinglearnresearchcommunity

for

Search:↓

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

PCOS can cause excess hair growth, oily skin, hair loss, acne, and dark skin patches.

Common dermatology drugs were considered but are controversial for COVID-19 treatment.

Acne is strongly linked to high BMI, hair loss, menstrual issues, family history, and eating too many sweets and fatty foods, but not to excessive hair growth.

Athletic trainers should understand and support the medical needs of transgender and gender-diverse patients.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

Hormonal therapy in adults with gender dysphoria often leads to skin issues like acne, requiring a team of skin and hormone doctors.

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.

Astragalus plants may improve skin health and have anti-aging benefits.

Nanotechnology offers promising new treatments for hair loss by improving targeted delivery and addressing key causes.

Rosemary shows promise in treating alopecia, similar to minoxidil, but more research is needed.

Combining plant extracts with nanotechnology may improve hair loss treatments.

Metformin might help treat certain skin conditions, but more research is needed.

The study suggests a possible increase in androgen receptors in patients with frontal fibrosing alopecia, but more research is needed.

Hormonal imbalances contribute to female hair loss, and trichoscopy is a useful diagnostic tool.

Metformin effectively reduces hormone levels in women with PCOS.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

PCOS is a common hormonal disorder in women that causes various symptoms and health risks, requiring personalized treatment.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Female pattern hair loss is different from male pattern hair loss and has unclear genetic causes.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Prenatal pesticide exposure may cause earlier breast development in girls.

Diagnosing and treating PCOS in teenagers is difficult, and the focus is on lifestyle changes and medication to improve health and prevent future issues.